Lesaffre to Present Yeast Ingredients for Women’s Health at Vitafoods Europe
The line is based around the company’s healthy-yeast ingredients, which have been shown in recent studies to help fight the pathogenic yeast Candida albicans, which is a prominent cause of vaginal infections.
Photo © iStockphoto.com/tunart
Lesaffre Human Care (Marcq-en-Baroeul, France) will present its new ingredient line for women’s health, Lynside VaginActiv, at the Vitafoods Europe trade show in Geneva. The line is based around the company’s healthy-yeast ingredients, which have been shown in recent studies to help fight the pathogenic yeast Candida albicans, which is a prominent cause of vaginal infections.
Currently, the Lynside VaginActiv line includes two products. The first is Lynside VaginActiv Oral, a probiotic yeast (Saccharomyces cerevisiae CNCM I-3856), meant for oral use, such as in the dietary supplements industry.
The second ingredient is Pharma VaginActiv Local, a dried yeast (Saccharomyces cerevisiae CNCM I-3856), which is designed for medical devices for vaginal applications, targeting the drug market.
The company adds that because the two ingredients offer “different responses to a common challenge, these two ingredients can be used individually or concomitantly to fight vaginal infections and prevent recurrence.”
According to the company, “Vulvovaginal candidiasis is in fact one of the most prevalent causes of vaginal infections in women of reproductive age and is characterized by the disruption of the vaginal microbiota composition. This unbalance favors opportunistic pathogen Candida albicans overgrowth.” The company says its ingredient can help, especially given the fact that over 75% of women worldwide experience at least one episode of vulvovaginal candidiasis in their life, with 4% to 8% suffering from recurrence (4 or more per year).
Also read:
Women's Dietary Supplements: Ingredients for Vaginal Health
Jennifer Grebow
Editor-in-Chief
Nutritional Outlook magazine
jennifer.grebow@ubm.com
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
